Zomedica Corp.Viés de alta
ZOM reaching denouement in symmetrical triangle
ZOM is about to reach the endpoint of it's symmetrical triangle. ZOM has been in the news a lot recently with the Carole Baskin mention and it also has a heavily patented technology coming out at the end of March. This stock has a great leadership team as well. Do you own do dill but I think this one is going up! Price target is $2.50.
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.